These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

696 related articles for article (PubMed ID: 26489865)

  • 1. Knockout of Epstein-Barr virus BPLF1 retards B-cell transformation and lymphoma formation in humanized mice.
    Whitehurst CB; Li G; Montgomery SA; Montgomery ND; Su L; Pagano JS
    mBio; 2015 Oct; 6(5):e01574-15. PubMed ID: 26489865
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Translesion Polymerase Pol η Is Required for Efficient Epstein-Barr Virus Infectivity and Is Regulated by the Viral Deubiquitinating Enzyme BPLF1.
    Dyson OF; Pagano JS; Whitehurst CB
    J Virol; 2017 Oct; 91(19):. PubMed ID: 28724765
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An EBNA3A-Mutated Epstein-Barr Virus Retains the Capacity for Lymphomagenesis in a Cord Blood-Humanized Mouse Model.
    Romero-Masters JC; Ohashi M; Djavadian R; Eichelberg MR; Hayes M; Zumwalde NA; Bristol JA; Nelson SE; Ma S; Ranheim EA; Gumperz JE; Johannsen EC; Kenney SC
    J Virol; 2020 May; 94(10):. PubMed ID: 32132242
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epstein-Barr Virus Type 2 Infects T Cells and Induces B Cell Lymphomagenesis in Humanized Mice.
    Coleman CB; Lang J; Sweet LA; Smith NA; Freed BM; Pan Z; Haverkos B; Pelanda R; Rochford R
    J Virol; 2018 Nov; 92(21):. PubMed ID: 30089703
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MicroRNAs of Epstein-Barr Virus Attenuate T-Cell-Mediated Immune Control
    Murer A; Rühl J; Zbinden A; Capaul R; Hammerschmidt W; Chijioke O; Münz C
    mBio; 2019 Jan; 10(1):. PubMed ID: 30647153
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Histone Loaders CAF1 and HIRA Restrict Epstein-Barr Virus B-Cell Lytic Reactivation.
    Zhang Y; Jiang C; Trudeau SJ; Narita Y; Zhao B; Teng M; Guo R; Gewurz BE
    mBio; 2020 Oct; 11(5):. PubMed ID: 33109754
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Rad6/18 ubiquitin complex interacts with the Epstein-Barr virus deubiquitinating enzyme, BPLF1, and contributes to virus infectivity.
    Kumar R; Whitehurst CB; Pagano JS
    J Virol; 2014 Jun; 88(11):6411-22. PubMed ID: 24672041
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epstein-Barr virus latent membrane protein-1 oncogene deletions: correlations with malignancy in Epstein-Barr virus--associated lymphoproliferative disorders and malignant lymphomas.
    Kingma DW; Weiss WB; Jaffe ES; Kumar S; Frekko K; Raffeld M
    Blood; 1996 Jul; 88(1):242-51. PubMed ID: 8704180
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Small molecule screening identifies inhibitors of the Epstein-Barr virus deubiquitinating enzyme, BPLF1.
    Atkins SL; Motaib S; Wiser LC; Hopcraft SE; Hardy PB; Shackelford J; Foote P; Wade AH; Damania B; Pagano JS; Pearce KH; Whitehurst CB
    Antiviral Res; 2020 Jan; 173():104649. PubMed ID: 31711927
    [TBL] [Abstract][Full Text] [Related]  

  • 10. EBNA3B-deficient EBV promotes B cell lymphomagenesis in humanized mice and is found in human tumors.
    White RE; Rämer PC; Naresh KN; Meixlsperger S; Pinaud L; Rooney C; Savoldo B; Coutinho R; Bödör C; Gribben J; Ibrahim HA; Bower M; Nourse JP; Gandhi MK; Middeldorp J; Cader FZ; Murray P; Münz C; Allday MJ
    J Clin Invest; 2012 Apr; 122(4):1487-502. PubMed ID: 22406538
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The reading frame BPLF1 of Epstein-Barr virus: a homologue of herpes simplex virus protein VP16.
    Schmaus S; Wolf H; Schwarzmann F
    Virus Genes; 2004 Oct; 29(2):267-77. PubMed ID: 15284487
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Latent Membrane Protein 1 (LMP1) and LMP2A Collaborate To Promote Epstein-Barr Virus-Induced B Cell Lymphomas in a Cord Blood-Humanized Mouse Model but Are Not Essential.
    Ma SD; Tsai MH; Romero-Masters JC; Ranheim EA; Huebner SM; Bristol JA; Delecluse HJ; Kenney SC
    J Virol; 2017 Apr; 91(7):. PubMed ID: 28077657
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An EBNA3C-deleted Epstein-Barr virus (EBV) mutant causes B-cell lymphomas with delayed onset in a cord blood-humanized mouse model.
    Romero-Masters JC; Ohashi M; Djavadian R; Eichelberg MR; Hayes M; Bristol JA; Ma S; Ranheim EA; Gumperz J; Johannsen EC; Kenney SC
    PLoS Pathog; 2018 Aug; 14(8):e1007221. PubMed ID: 30125329
    [TBL] [Abstract][Full Text] [Related]  

  • 14. LMP1-deficient Epstein-Barr virus mutant requires T cells for lymphomagenesis.
    Ma SD; Xu X; Plowshay J; Ranheim EA; Burlingham WJ; Jensen JL; Asimakopoulos F; Tang W; Gulley ML; Cesarman E; Gumperz JE; Kenney SC
    J Clin Invest; 2015 Jan; 125(1):304-15. PubMed ID: 25485679
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An Epstein-Barr Virus (EBV) mutant with enhanced BZLF1 expression causes lymphomas with abortive lytic EBV infection in a humanized mouse model.
    Ma SD; Yu X; Mertz JE; Gumperz JE; Reinheim E; Zhou Y; Tang W; Burlingham WJ; Gulley ML; Kenney SC
    J Virol; 2012 Aug; 86(15):7976-87. PubMed ID: 22623780
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A new model of Epstein-Barr virus infection reveals an important role for early lytic viral protein expression in the development of lymphomas.
    Ma SD; Hegde S; Young KH; Sullivan R; Rajesh D; Zhou Y; Jankowska-Gan E; Burlingham WJ; Sun X; Gulley ML; Tang W; Gumperz JE; Kenney SC
    J Virol; 2011 Jan; 85(1):165-77. PubMed ID: 20980506
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A cluster of virus-encoded microRNAs accelerates acute systemic Epstein-Barr virus infection but does not significantly enhance virus-induced oncogenesis in vivo.
    Wahl A; Linnstaedt SD; Esoda C; Krisko JF; Martinez-Torres F; Delecluse HJ; Cullen BR; Garcia JV
    J Virol; 2013 May; 87(10):5437-46. PubMed ID: 23468485
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epstein-Barr virus large tegument protein BPLF1 contributes to innate immune evasion through interference with toll-like receptor signaling.
    van Gent M; Braem SG; de Jong A; Delagic N; Peeters JG; Boer IG; Moynagh PN; Kremmer E; Wiertz EJ; Ovaa H; Griffin BD; Ressing ME
    PLoS Pathog; 2014 Feb; 10(2):e1003960. PubMed ID: 24586164
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interactions involving cyclosporine A, interleukin-6, and Epstein-Barr virus lead to the promotion of B-cell lymphoproliferative disease.
    Tanner JE; Alfieri C
    Leuk Lymphoma; 1996 May; 21(5-6):379-90. PubMed ID: 9172802
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epstein-Barr Virus-Positive Lymphomas Exploit Ectonucleotidase Activity To Limit Immune Responses and Prevent Cell Death.
    Lange PT; Damania B
    mBio; 2023 Apr; 14(2):e0345922. PubMed ID: 36786572
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 35.